This brand name is authorized in Nigeria.
The drug HYPEREX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
3L36P16U4R - RABEPRAZOLE SODIUM
|
|
Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump). |
|
2
|
UNII
5587267Z69 - DOMPERIDONE
|
|
Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-4789 | Capsule | HYPEREX-SR Capsules CAP 30 mg; 20 mg 1 X 10 | 98 RNW-PP-176274 HYPEREX-SR Capsules RABEPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES RABEPRAZOLE SODIUM & DOMPERIDONE (SR) Excipients: Microcrystalline cellulose Lactose monohydrate Maize starch Povidone K30 Sodium lauryl sulphate Silica colloidal, anhydrous Magnesium stearate B4-4789 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 11/13/2020 LEOTETRA HEALTHCARE LTD, GIDA NA'ADADE NAIBAWA KANO KANO 8066471561 leotetranigltd@outlook.com INNOVA CAPTAB PVT. LTD, 81-B, EPIP PHASE – 1 JHARMAJRI, BADDI (H.P) PIN – 173205 INDIA. , India | 30/11/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A02BC54 | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-4789 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.